CD26 and CD30 expression on the surface of lymphocyte during normal pregnancy

被引:1
|
作者
Hoshimoto, K [1 ]
Hayashi, M [1 ]
Ohkura, T [1 ]
机构
[1] Dokkyo Univ, Sch Med, Dept Obstet & Gynecol, Koshigaya Hosp, Koshigaya, Saitama 343, Japan
关键词
CD26; expression; CD30; lymphocyte; pregnancy; cytokine balance;
D O I
10.1159/000052932
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
It is increasingly apparent that the Th1/Th2 cell ratio is decreased during pregnancy. In a previous study, we revealed that combined analysis of soluble CD26 and CD30 might be a potent surrogate tool for evaluating the Th1/Th2 balance during pregnancy. Therefore, in the present study, we elucidated whether the CD26 and CD30 expression on the surface of lymphocyte is useful marker for Th1 and Th2 lymphocytes, respectively, during pregnancy with flow cytometric technique. The peripheral blood samples were obtained from 6 non-pregnant healthy women, 8 healthy pregnant women in the first trimester and 12 pregnant women in the third trimester. The mean percentages of CD26 expression did not differ significantly among these groups (p = 0.45). Also, the mean percentages of CD30 expression did not differ significantly among these groups (p = 0.32). From the present study, the expression of CD26 and CD30 did not appear to be a useful marker for Th1 and Th2 lymphocytes during pregnancy. Copyright (C) 2001 S. Karger AG, Basel.
引用
收藏
页码:9 / 12
页数:4
相关论文
共 50 条
  • [31] The Polyvalent Role of CD30 for Cancer Diagnosis and Treatment
    Dumitru, Adrian Vasile
    Tapoi, Dana Antonia
    Halcu, Georgian
    Munteanu, Octavian
    Dumitrascu, David-Ioan
    Ceausu, Mihail Constantin
    Gheorghisan-Galateanu, Ancuta-Augustina
    CELLS, 2023, 12 (13)
  • [32] CD26/DPP-4 in Chronic Myeloid Leukemia
    Sicuranza, Anna
    Raspadori, Donatella
    Bocchia, Monica
    CANCERS, 2022, 14 (04)
  • [33] CD30, another useful predictor of survival in DLBCL?
    Chan, Wing C.
    BLOOD, 2013, 121 (14) : 2582 - 2583
  • [34] Soluble CD30 Levels in Patients with Rheumatoid Arthritis
    Tur, Birkan Sonel
    Ataman, Sebnem
    Suldur, Nurben
    Duzgun, Nursen
    Atay, Mesut Birol
    TURKISH JOURNAL OF RHEUMATOLOGY, 2009, 24 (03) : 131 - 135
  • [35] CD4 and CD30 Coexpression in a Cutaneous Manifestation of Systemic Mastocytosis - A Pitfall
    Kulberg, Aleksandra
    Mitteldorf, Christina
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2018, 40 (08) : 628 - 630
  • [36] CD30 Is Required for CCL21 Expression and CD4 T Cell Recruitment in the Absence of Lymphotoxin Signals
    Bekiaris, Vasileios
    Gaspal, Fabrina
    Kim, Mi-Yeon
    Withers, David R.
    McConnell, Fiona M.
    Anderson, Graham
    Lane, Peter J. L.
    JOURNAL OF IMMUNOLOGY, 2009, 182 (08) : 4771 - 4775
  • [37] DIPEPTIDYL PEPTIDASE IV (CD26) ACTIVITY IN DIFFERENT LYMPHOCYTE POPULATIONS OF HUMAN PERIPHERAL BLOOD AFTER MITOGEN STIMULATION
    Dimitrova, Mashenka
    Ivanov, Ivaylo
    Georgieva, Lillia
    Nikolova, Elena
    COMPTES RENDUS DE L ACADEMIE BULGARE DES SCIENCES, 2009, 62 (05): : 603 - 608
  • [38] Synergistic OX40 and CD30 signals sustain CD8+ T cells during antigenic challenge
    Bekiaris, Vasileios
    Gaspal, Fabrina
    Kim, Mi-Yeon
    Withers, David R.
    Sweet, Clive
    Anderson, Graham
    Lane, Peter J. L.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2009, 39 (08) : 2120 - 2125
  • [39] CD26/Dipeptidyl Peptidase IV and Its Multiple Biological Functions
    Pan, Kelsey
    Ohnuma, Kei
    Morimoto, Chikao
    Dang, Nam H.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (02)
  • [40] CD26 as a Promising Biomarker for Predicting Prognosis in Patients with Pancreatic Tumors
    Yan, Liang
    Tian, Xiuyun
    Ye, Chunxiang
    Guan, Xiaoya
    Dong, Bin
    Zhao, Min
    Wu, Jianhui
    Hao, Chunyi
    ONCOTARGETS AND THERAPY, 2020, 13 : 12615 - 12623